2026-07-16T14:21:40Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/231722024-11-29T06:08:14Zcom_20.500.12105_15322com_20.500.12105_2051col_20.500.12105_16967

00925njm 22002777a 4500 dc Molero-Garcia, Jose Maria author Arranz-Izquierdo, Javier author Gutierrez-Perez, Maria Isabel author Redondo Sanchez, Jesus Maria author 2021-06 SARS-CoV-2 is transmitted from person to person by inhalation or contact with respiratory droplets and aerosols. The median incubation period is 5.1 days. Fever, dry cough, dyspnea and fatigue are the most common symptoms. Almost half of the cases are asymptomatic. The spectrum of disease varies from mild (81%) to critical (5%). Older age, male gender and comorbilidades negatively impact on the severity and mortality of COVID-19. The diagnosis of acute COVID-19 is made with RT-PCR or antigenica detection tests. In hospital patients, remdesivir reduces recovery time. Oral steroids are recommended for severe or critical cases requiring oxygen therapy or mechanical ventilation. Thromboprophylaxis is recommended in all severe and non-severe cases with high thrombotic risk. Antibiotherapy is limited to cases of high suspicion of bacterial superinfection. Mild-moderate and severe cases after discharge from hospital should be clinically monitored for a minimum period of two weeks (C) 2020 Published by Elsevier Espana, S.L.U. Molero-Garcia JM, Arranz-Izquierdo J, Gutierrez-Perez MI, Sanchez JMR. Basic aspects of COVID-19 for management from primary care. Aten Prim. 2021 Jun-Jul;53(6):101966. 10.1016/j.aprim.2020.12.007 1578-1275 0212-6567 Atencion Primaria https://hdl.handle.net/20.500.13003/19463 33852979 L2011656026 2-s2.0-85103935982 https://hdl.handle.net/20.500.12105/23172 663040600001 COVID-19 Family practice COVID-19 diagnostic testing COVID-19 drug treatment Long COVID Basic aspects of COVID-19 for management from primary care